Related studies have shown that changes in M6A regulatory genes could promote the progression of breast cancer, liver cancer, and hematological malignant tumors by inducing the formation of cancer stem cells and their abnormal differentiation [8–10]. The gene discussed is METTL3; the disease is cancer.